North America
US firm Mederi Therapeutics bags $18.5M in Series B for GERD and bowel incontinence treatment
Connecticut, US-based pharmaceutical firm Mederi Therapeutics raised $18.5 million in a Series B funding round for the sales and marketing of its treatment for Gastrointestinal Reflux Disease (GERD) and fecal incontinence.
Insurers need to be watched - FT
The problems of Britian-based insurer RSA is a reminder that politicians, regulators and the general public should also put the spotlight on insurance companies and not just banks.
Fidelity Investments changes managers at two dividend growth funds
Lawrence Rakers will be replaced by Ramona Persaud as the manager of Fidelity Dividend Growth Fund and Fidelity Advisor Dividend Growth Fund starting January 1, Bloomberg reported.
Fortress backs new LightSquared bankruptcy exit plan
LightSquared is proposing a new bankruptcy exit plan with financing from Fortress Investment Group and other backers, as the U.S. wireless communications company seeks to avoid a sale to highest bidder Dish Network Corp.




